Annual revenue:
$4.05B-$79.42M(-1.92%)Summary
- As of today (May 6, 2025), CRL annual revenue is $4.05 billion, with the most recent change of -$79.42 million (-1.92%) on December 28, 2024.
- During the last 3 years, CRL annual revenue has risen by +$509.83 million (+14.40%).
- CRL annual revenue is now -1.92% below its all-time high of $4.13 billion, reached on December 30, 2023.
Performance
CRL Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$1.00B-$7.21M(-0.71%)Summary
- As of today (May 6, 2025), CRL quarterly revenue is $1.00 billion, with the most recent change of -$7.21 million (-0.71%) on December 28, 2024.
- Over the past year, CRL quarterly revenue has dropped by -$10.93 million (-1.08%).
- CRL quarterly revenue is now -8.85% below its all-time high of $1.10 billion, reached on December 31, 2022.
Performance
CRL Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$4.05B-$10.93M(-0.27%)Summary
- As of today (May 6, 2025), CRL TTM revenue is $4.05 billion, with the most recent change of -$10.93 million (-0.27%) on December 28, 2024.
- Over the past year, CRL TTM revenue has dropped by -$79.42 million (-1.92%).
- CRL TTM revenue is now -3.93% below its all-time high of $4.22 billion, reached on September 30, 2023.
Performance
CRL TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
CRL Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.9% | -1.1% | -1.9% |
| 3 y3 years | +14.4% | +10.8% | +14.4% |
| 5 y5 years | +54.5% | +45.1% | +48.7% |
CRL Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1.9% | +14.4% | -8.8% | +9.7% | -3.9% | +11.6% |
| 5 y | 5-year | -1.9% | +54.5% | -8.8% | +46.9% | -3.9% | +48.7% |
| alltime | all time | -1.9% | +1995.2% | -8.8% | +1282.8% | -3.9% | +5486.0% |
Charles River Laboratories International Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $4.05B(-1.9%) | $1.00B(-0.7%) | $4.05B(-0.3%) |
| Sep 2024 | - | $1.01B(-1.6%) | $4.06B(-0.4%) |
| Jun 2024 | - | $1.03B(+1.4%) | $4.08B(-0.8%) |
| Mar 2024 | - | $1.01B(-0.2%) | $4.11B(-0.4%) |
| Dec 2023 | $4.13B(+3.9%) | $1.01B(-1.3%) | $4.13B(-2.0%) |
| Sep 2023 | - | $1.03B(-3.1%) | $4.22B(+0.9%) |
| Jun 2023 | - | $1.06B(+3.0%) | $4.18B(+2.1%) |
| Mar 2023 | - | $1.03B(-6.4%) | $4.09B(+2.9%) |
| Dec 2022 | $3.98B(+12.3%) | $1.10B(+11.2%) | $3.98B(+5.2%) |
| Sep 2022 | - | $989.16M(+1.6%) | $3.78B(+2.5%) |
| Jun 2022 | - | $973.13M(+6.5%) | $3.69B(+1.6%) |
| Mar 2022 | - | $913.93M(+1.0%) | $3.63B(+2.5%) |
| Dec 2021 | $3.54B(+21.1%) | $905.05M(+1.0%) | $3.54B(+3.3%) |
| Sep 2021 | - | $895.94M(-2.0%) | $3.43B(+4.7%) |
| Jun 2021 | - | $914.61M(+10.9%) | $3.27B(+7.6%) |
| Mar 2021 | - | $824.57M(+4.2%) | $3.04B(+4.0%) |
| Dec 2020 | $2.92B(+11.5%) | $790.99M(+6.4%) | $2.92B(+3.5%) |
| Sep 2020 | - | $743.30M(+8.9%) | $2.82B(+2.7%) |
| Jun 2020 | - | $682.58M(-3.5%) | $2.75B(+0.9%) |
| Mar 2020 | - | $707.06M(+2.3%) | $2.72B(+3.9%) |
| Dec 2019 | $2.62B(+15.7%) | $691.14M(+3.5%) | $2.62B(+3.5%) |
| Sep 2019 | - | $667.95M(+1.6%) | $2.53B(+3.4%) |
| Jun 2019 | - | $657.57M(+8.8%) | $2.45B(+3.0%) |
| Mar 2019 | - | $604.57M(+0.5%) | $2.38B(+4.9%) |
| Dec 2018 | $2.27B(+22.0%) | $601.53M(+2.8%) | $2.27B(+5.7%) |
| Sep 2018 | - | $585.29M(-0.0%) | $2.14B(+6.0%) |
| Jun 2018 | - | $585.30M(+18.5%) | $2.02B(+6.1%) |
| Mar 2018 | - | $493.97M(+3.2%) | $1.91B(+2.6%) |
| Dec 2017 | $1.86B(+10.5%) | $478.48M(+3.1%) | $1.86B(+0.6%) |
| Sep 2017 | - | $464.23M(-1.0%) | $1.85B(+2.1%) |
| Jun 2017 | - | $469.13M(+5.2%) | $1.81B(+2.0%) |
| Mar 2017 | - | $445.76M(-4.5%) | $1.77B(+5.4%) |
| Dec 2016 | $1.68B(+23.3%) | $466.79M(+9.6%) | $1.68B(+7.2%) |
| Sep 2016 | - | $425.72M(-1.9%) | $1.57B(+5.1%) |
| Jun 2016 | - | $434.06M(+22.3%) | $1.49B(+6.8%) |
| Mar 2016 | - | $354.87M(+0.3%) | $1.40B(+2.5%) |
| Dec 2015 | $1.36B(+5.1%) | $353.85M(+1.3%) | $1.36B(+1.8%) |
| Sep 2015 | - | $349.46M(+2.9%) | $1.34B(+1.7%) |
| Jun 2015 | - | $339.57M(+6.0%) | $1.32B(-0.1%) |
| Mar 2015 | - | $320.41M(-2.8%) | $1.32B(+1.6%) |
| Dec 2014 | $1.30B(+11.3%) | $329.55M(+0.6%) | $1.30B(+3.2%) |
| Sep 2014 | - | $327.57M(-4.0%) | $1.26B(+2.9%) |
| Jun 2014 | - | $341.18M(+14.0%) | $1.22B(+4.1%) |
| Mar 2014 | - | $299.37M(+3.5%) | $1.17B(+0.7%) |
| Dec 2013 | $1.17B(+3.2%) | $289.23M(-1.0%) | $1.17B(+0.8%) |
| Sep 2013 | - | $292.13M(-0.3%) | $1.16B(+1.2%) |
| Jun 2013 | - | $292.93M(+0.6%) | $1.14B(+0.7%) |
| Mar 2013 | - | $291.24M(+4.0%) | $1.13B(+0.5%) |
| Dec 2012 | $1.13B | $280.14M(+0.5%) | $1.13B(-0.9%) |
| Sep 2012 | - | $278.69M(-2.1%) | $1.14B(+0.1%) |
| Jun 2012 | - | $284.72M(-0.4%) | $1.14B(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $285.98M(-1.7%) | $1.14B(+0.0%) |
| Dec 2011 | $1.14B(+0.8%) | $290.96M(+4.8%) | $1.14B(+0.8%) |
| Sep 2011 | - | $277.58M(-3.7%) | $1.13B(+0.6%) |
| Jun 2011 | - | $288.26M(+0.8%) | $1.13B(-0.0%) |
| Mar 2011 | - | $285.84M(+1.5%) | $1.13B(-0.6%) |
| Dec 2010 | $1.13B(-3.3%) | $281.65M(+4.0%) | $1.13B(+1.5%) |
| Sep 2010 | - | $270.88M(-6.1%) | $1.12B(-2.3%) |
| Jun 2010 | - | $288.59M(-1.3%) | $1.14B(-1.7%) |
| Mar 2010 | - | $292.29M(+10.5%) | $1.16B(-0.8%) |
| Dec 2009 | $1.17B(-12.8%) | $264.47M(-11.1%) | $1.17B(-3.9%) |
| Sep 2009 | - | $297.49M(-3.5%) | $1.22B(-3.5%) |
| Jun 2009 | - | $308.16M(+2.2%) | $1.26B(-3.4%) |
| Mar 2009 | - | $301.53M(-3.2%) | $1.31B(-2.7%) |
| Dec 2008 | $1.34B(+9.2%) | $311.45M(-9.0%) | $1.34B(-0.5%) |
| Sep 2008 | - | $342.23M(-2.8%) | $1.35B(+2.1%) |
| Jun 2008 | - | $352.13M(+4.3%) | $1.32B(+3.5%) |
| Mar 2008 | - | $337.69M(+6.2%) | $1.28B(+3.8%) |
| Dec 2007 | $1.23B(+16.3%) | $318.03M(+1.3%) | $1.23B(+3.9%) |
| Sep 2007 | - | $313.96M(+2.1%) | $1.18B(+4.3%) |
| Jun 2007 | - | $307.44M(+5.6%) | $1.14B(+3.6%) |
| Mar 2007 | - | $291.20M(+7.2%) | $1.10B(+3.5%) |
| Dec 2006 | $1.06B(+6.5%) | $271.73M(+2.7%) | $1.06B(+11.5%) |
| Sep 2006 | - | $264.66M(-1.2%) | $948.91M(-1.0%) |
| Jun 2006 | - | $267.86M(+5.4%) | $958.19M(+1.8%) |
| Mar 2006 | - | $254.14M(+56.6%) | $941.22M(-2.0%) |
| Dec 2005 | $993.33M(+37.2%) | $162.25M(-40.8%) | $960.80M(-3.3%) |
| Sep 2005 | - | $273.94M(+9.2%) | $993.91M(+10.9%) |
| Jun 2005 | - | $250.89M(-8.3%) | $896.00M(+8.6%) |
| Mar 2005 | - | $273.72M(+40.1%) | $825.31M(+14.0%) |
| Dec 2004 | $724.22M(+18.0%) | $195.37M(+11.0%) | $724.22M(+5.7%) |
| Sep 2004 | - | $176.03M(-2.3%) | $684.90M(+3.8%) |
| Jun 2004 | - | $180.19M(+4.4%) | $660.06M(+4.1%) |
| Mar 2004 | - | $172.64M(+10.6%) | $634.24M(+3.3%) |
| Dec 2003 | $613.72M(+10.7%) | $156.04M(+3.2%) | $613.72M(+2.2%) |
| Sep 2003 | - | $151.19M(-2.1%) | $600.63M(+1.7%) |
| Jun 2003 | - | $154.36M(+1.5%) | $590.80M(+3.1%) |
| Mar 2003 | - | $152.13M(+6.4%) | $572.93M(+3.3%) |
| Dec 2002 | $554.63M(+19.1%) | $142.94M(+1.1%) | $554.63M(+3.1%) |
| Sep 2002 | - | $141.36M(+3.6%) | $537.78M(+3.4%) |
| Jun 2002 | - | $136.50M(+2.0%) | $520.10M(+3.9%) |
| Mar 2002 | - | $133.82M(+6.1%) | $500.42M(+7.5%) |
| Dec 2001 | $465.63M(+51.9%) | $126.09M(+1.9%) | $465.63M(+10.7%) |
| Sep 2001 | - | $123.69M(+5.9%) | $420.59M(+12.9%) |
| Jun 2001 | - | $116.82M(+18.0%) | $372.50M(+11.8%) |
| Mar 2001 | - | $99.03M(+22.2%) | $333.11M(+8.7%) |
| Dec 2000 | $306.58M(+32.5%) | $81.06M(+7.2%) | $306.58M(+35.9%) |
| Sep 2000 | - | $75.59M(-2.4%) | $225.53M(+50.4%) |
| Jun 2000 | - | $77.43M(+6.8%) | $149.93M(+106.8%) |
| Mar 2000 | - | $72.50M | $72.50M |
| Dec 1999 | $231.41M(+19.7%) | - | - |
| Dec 1998 | $193.30M | - | - |
FAQ
- What is Charles River Laboratories International annual revenue?
- What is the all time high annual revenue for Charles River Laboratories International?
- What is Charles River Laboratories International annual revenue year-on-year change?
- What is Charles River Laboratories International quarterly revenue?
- What is the all time high quarterly revenue for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly revenue year-on-year change?
- What is Charles River Laboratories International TTM revenue?
- What is the all time high TTM revenue for Charles River Laboratories International?
- What is Charles River Laboratories International TTM revenue year-on-year change?
What is Charles River Laboratories International annual revenue?
The current annual revenue of CRL is $4.05B
What is the all time high annual revenue for Charles River Laboratories International?
Charles River Laboratories International all-time high annual revenue is $4.13B
What is Charles River Laboratories International annual revenue year-on-year change?
Over the past year, CRL annual revenue has changed by -$79.42M (-1.92%)
What is Charles River Laboratories International quarterly revenue?
The current quarterly revenue of CRL is $1.00B
What is the all time high quarterly revenue for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly revenue is $1.10B
What is Charles River Laboratories International quarterly revenue year-on-year change?
Over the past year, CRL quarterly revenue has changed by -$10.93M (-1.08%)
What is Charles River Laboratories International TTM revenue?
The current TTM revenue of CRL is $4.05B
What is the all time high TTM revenue for Charles River Laboratories International?
Charles River Laboratories International all-time high TTM revenue is $4.22B
What is Charles River Laboratories International TTM revenue year-on-year change?
Over the past year, CRL TTM revenue has changed by -$79.42M (-1.92%)